7. Financing Cures

Science has entered a thrilling new era. Study of the human genome has brought us tantalizingly close to discoveries that can reduce suffering and save lives. But translating research into real treatments is a tortuous process that requires major long-term investment and no small risk of failure.

At the very moment when profound new breakthroughs seem to be within our grasp, there has been a precipitous decline in financing for early-stage biomedical research. This constraint is first and foremost a tragedy for those individuals who are waiting desperately for cures. It is also a factor that limits productivity gains in the global economy and keeps developing nations mired in poverty.

Large pharmaceutical companies, with their ...

Get Financial Innovation (Collection) now with O’Reilly online learning.

O’Reilly members experience live online training, plus books, videos, and digital content from 200+ publishers.